Prostate Cancer - Results from #23540

Course of the type of patient who is candidate for radical prostatectomy over 2 decades (1989-2009) - Abstract March 28, 2013

Relationship of early-onset baldness to prostate cancer in African-American men - Abstract March 28, 2013

EDAP receives U.S. FDA filing acceptance of pre-market approval application March 28, 2013

Urological medical oncology: Land of opportunity - Abstract March 28, 2013

Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer - Abstract March 27, 2013

Predictors for positive surgical margins after robot-assisted radical prostatectomy: A single surgeon's series in Japan - Abstract March 27, 2013

Statin therapy is not associated with prostate cancer recurrence among patients who underwent radiation therapy - Abstract March 27, 2013

Margin status is a very important prognostic factor for patients with pT3b prostate cancer - Abstract March 27, 2013

Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography - Abstract March 27, 2013

Tumor cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases - Abstract March 27, 2013

Impact of advanced age on biochemical recurrence after radical prostatectomy in Japanese men according to pathological stage - Abstract March 27, 2013

Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer - Abstract March 27, 2013

Psychosocial aspects of active surveillance - Abstract March 27, 2013

Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy - Abstract March 26, 2013

Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer over 15 years - Abstract March 26, 2013

Nine-year outcome and toxicity in patients treated with IMRT for localized prostate cancer - Abstract March 26, 2013

Intraoperative frozen section of the prostate reduces positive margin rates while ensuring nerve-sparing procedure during radical prostatectomy - Abstract March 26, 2013

Incidence and pathologic features of prostate cancer detected on transperineal template-guided mapping biopsy following negative transrectal ultrasound-guided biopsy - Abstract March 26, 2013

PROGENSA®PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: A prospective multicenter clinical study - Abstract March 26, 2013

Management of biochemically recurrent prostate cancer after local therapy: Evolving standards of care and new directions - Abstract March 26, 2013

Page 1178 of 1435